Description for Lysophosphatidylethanolamine
Lipid Lysophosphatidylethanolamine
Species Homo sapiens
 Lysophosphatidylethanolamine identified in exosomes derived from the following tissue/cell type
Melanoma cells [Exosomes/Microvesicles] 23767874   
Plasma [Microparticles] 11878797   
Prostate cancer cells [Exosomes/Microvesicles] 24046871   
 Experiment description of studies that identified Lysophosphatidylethanolamine in exosomes
1
Experiment ID528
Identified moleculeLipid
Identification method Mass spectrometry
PubMed ID 23767874   
OrganismHomo sapiens
Experiment descriptionBiochemical and biological characterization of exosomes containing prominin-1/CD133.
AuthorsRappa G, Mercapide J, Anzanello F, Pope RM, Lorico A.
Journal name Mol Cancer
Publication year2013
SampleMelanoma cells
Sample nameMalignant melanoma (FEMX-I)
Molecules identified in the studyLipids
Methods used in the studyMass spectrometry
EV-TRACK EV130053: EV-METRIC:33%, 33%
2
Experiment ID365
Identified moleculeLipid
Identification method TLC
PubMed ID 11878797   
OrganismHomo sapiens
Experiment descriptionPhospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography.
AuthorsWeerheim AM1, Kolb AM, Sturk A, Nieuwland R.
Journal name Anal Biochem
Publication year2002
SamplePlasma
Sample nameNormal-Plasma
Molecules identified in the studyLipids
Methods used in the studyThin layer chromatography
EV-TRACK -
3
Experiment ID555
Identified moleculeLipid
Identification method Mass spectrometry
PubMed ID 24046871   
OrganismHomo sapiens
Experiment descriptionMolecular lipidomics of exosomes released by PC-3 prostate cancer cells.
AuthorsLlorente A, Skotland T, SylvÃnne T, Kauhanen D, Róg T, Orłowski A, Vattulainen I, Ekroos K, Sandvig K.
Journal name Biochim Biophys Acta
Publication year2013
SampleProstate cancer cells
Sample namePC3
Molecules identified in the studyLipids
Methods used in the studyMass spectrometry
EV-TRACK EV130205: EV-METRIC:14%